Maternal Influenza Immunization and Reduced Likelihood of Prematurity and Small for Gestational Age Births: A Retrospective Cohort Study
Background:
Infections during pregnancy have the potential to adversely impact birth outcomes. We evaluated the association between receipt of inactivated influenza vaccine during pregnancy and prematurity and small for gestational age (SGA) births.
Methods and Findings:
We conducted a cohort analysis of surveillance data from the Georgia (United States) Pregnancy Risk Assessment Monitoring System. Among 4,326 live births between 1 June 2004 and 30 September 2006, maternal influenza vaccine information was available for 4,168 (96.3%). The primary intervention evaluated in this study was receipt of influenza vaccine during any trimester of pregnancy. The main outcome measures were prematurity (gestational age at birth <37 wk) and SGA (birth weight <10th percentile for gestational age). Infants who were born during the putative influenza season (1 October–31 May) and whose mothers were vaccinated against influenza during pregnancy were less likely to be premature compared to infants of unvaccinated mothers born in the same period (adjusted odds ratio [OR] = 0.60; 95% CI, 0.38–0.94). The magnitude of association between maternal influenza vaccine receipt and reduced likelihood of prematurity increased during the period of at least local influenza activity (adjusted OR = 0.44; 95% CI, 0.26–0.73) and was greatest during the widespread influenza activity period (adjusted OR = 0.28; 95% CI, 0.11–0.74). Compared with newborns of unvaccinated women, newborns of vaccinated mothers had 69% lower odds of being SGA (adjusted OR = 0.31; 95% CI, 0.13–0.75) during the period of widespread influenza activity. The adjusted and unadjusted ORs were not significant for the pre-influenza activity period.
Conclusions:
This study demonstrates an association between immunization with the inactivated influenza vaccine during pregnancy and reduced likelihood of prematurity during local, regional, and widespread influenza activity periods. However, no associations were found for the pre-influenza activity period. Moreover, during the period of widespread influenza activity there was an association between maternal receipt of influenza vaccine and reduced likelihood of SGA birth.
: Please see later in the article for the Editors' Summary
Vyšlo v časopise:
Maternal Influenza Immunization and Reduced Likelihood of Prematurity and Small for Gestational Age Births: A Retrospective Cohort Study. PLoS Med 8(5): e32767. doi:10.1371/journal.pmed.1000441
Kategorie:
Research Article
prolekare.web.journal.doi_sk:
https://doi.org/10.1371/journal.pmed.1000441
Souhrn
Background:
Infections during pregnancy have the potential to adversely impact birth outcomes. We evaluated the association between receipt of inactivated influenza vaccine during pregnancy and prematurity and small for gestational age (SGA) births.
Methods and Findings:
We conducted a cohort analysis of surveillance data from the Georgia (United States) Pregnancy Risk Assessment Monitoring System. Among 4,326 live births between 1 June 2004 and 30 September 2006, maternal influenza vaccine information was available for 4,168 (96.3%). The primary intervention evaluated in this study was receipt of influenza vaccine during any trimester of pregnancy. The main outcome measures were prematurity (gestational age at birth <37 wk) and SGA (birth weight <10th percentile for gestational age). Infants who were born during the putative influenza season (1 October–31 May) and whose mothers were vaccinated against influenza during pregnancy were less likely to be premature compared to infants of unvaccinated mothers born in the same period (adjusted odds ratio [OR] = 0.60; 95% CI, 0.38–0.94). The magnitude of association between maternal influenza vaccine receipt and reduced likelihood of prematurity increased during the period of at least local influenza activity (adjusted OR = 0.44; 95% CI, 0.26–0.73) and was greatest during the widespread influenza activity period (adjusted OR = 0.28; 95% CI, 0.11–0.74). Compared with newborns of unvaccinated women, newborns of vaccinated mothers had 69% lower odds of being SGA (adjusted OR = 0.31; 95% CI, 0.13–0.75) during the period of widespread influenza activity. The adjusted and unadjusted ORs were not significant for the pre-influenza activity period.
Conclusions:
This study demonstrates an association between immunization with the inactivated influenza vaccine during pregnancy and reduced likelihood of prematurity during local, regional, and widespread influenza activity periods. However, no associations were found for the pre-influenza activity period. Moreover, during the period of widespread influenza activity there was an association between maternal receipt of influenza vaccine and reduced likelihood of SGA birth.
: Please see later in the article for the Editors' Summary
Zdroje
1. GoodnightWH
SoperDE
2005 Pneumonia in pregnancy. Crit Care Med 33 S390 S397
2. HardyJM
AzarowiczEN
ManniniA
MedearisDNJr
CookeRE
1961 The effect of Asian influenza on the outcome of pregnancy, Baltimore, 1957–1958. Am J Public Health Nations Health 51 1182 1188
3. MakTK
MangtaniP
LeeseJ
WatsonJM
PfeiferD
2008 Influenza vaccination in pregnancy: current evidence and selected national policies. Lancet Infect Dis 8 44 52
4. ZamanK
RoyE
ArifeenSE
RahmanM
RaqibR
2008 Effectiveness of maternal influenza immunization in mothers and infants. N Engl J Med 359 1555 1564
5. GoldenbergRL
CulhaneJF
IamsJD
RomeroR
2008 Epidemiology and causes of preterm birth. Lancet 371 75 84
6. RomeroR
EspinozaJ
GoncalvesLF
KusanovicJP
FrielL
2007 The role of inflammation and infection in preterm birth. Semin Reprod Med 25 21 39
7. Centers for Disease Control and Prevention 2009 Pregnancy Risk Assessment Monitoring System (PRAMS): home. Available: http://www.cdc.gov/prams/. Accessed 29 April 2011
8. Georgia Department of Community Health 2009 What is Georgia PRAMS? Available: http://health.state.ga.us/epi/prams/index.asp. Accessed 29 April 2011
9. OkenE
KleinmanKP
Rich-EdwardsJ
GillmanMW
2003 A nearly continuous measure of birth weight for gestational age using a United States national reference. BMC Pediatr 3 6
10. Georgia Department of Community Health 2009 Influenza surveillance in Georgia. Available: http://health.state.ga.us/epi/flu/. Accessed 29 April 2011
11. JacksonML
NelsonJC
WeissNS
NeuzilKM
BarlowW
2008 Influenza vaccination and risk of community-acquired pneumonia in immunocompetent elderly people: a population-based, nested case-control study. Lancet 372 398 405
12. NelsonJC
JacksonML
WeissNS
JacksonLA
2009 New strategies are needed to improve the accuracy of influenza vaccine effectiveness estimates among seniors. J Clin Epidemiol 62 687 694
13. Centers for Disease Control and Prevention 2008 Pregnancy Risk Assessment Monitoring System (PRAMS): methodology. Available: http://www.cdc.gov/prams/methodology.htm. Accessed 29 April 2011
14. KleinbaumDG
KupperLL
MorgensternH
1982 Epidemiologic research: principles and quantitative methods New York John Wiley & Sons
15. RaoJNK
SottAJ
1984 On chi-squared tests for multiway contingency tables with cell proportions estimated from survey data. Ann Stat 12 46 60
16. Centers for Disease Control and Prevention 2006 2005–06 U.S. influenza season summary. Available: http://www.cdc.gov/flu/weekly/weeklyarchives2005-2006/05-06summary.htm. Accessed 29 April 2011
17. IrvingWL
JamesDK
StephensonT
LaingP
JamesonC
2000 Influenza virus infection in the second and third trimesters of pregnancy: a clinical and seroepidemiological study. BJOG 107 1282 1289
18. RasmussenSA
JamiesonDJ
MacfarlaneK
CraganJD
WilliamsJ
2009 Pandemic influenza and pregnant women: summary of a meeting of experts. Am J Public Health 99 Suppl 2 S248 S254
19. UchideN
OhyamaK
BesshoT
ToyodaH
2005 Induction of pro-inflammatory cytokine gene expression and apoptosis in human chorion cells of fetal membranes by influenza virus infection: possible implications for maintenance and interruption of pregnancy during infection. Med Sci Monit 11 RA7 16
20. RomeroR
DurumS
DinarelloCA
OyarzunE
HobbinsJC
1989 Interleukin-1 stimulates prostaglandin biosynthesis by human amnion. Prostaglandins 37 13 22
21. ChallisJR
SlobodaDM
AlfaidyN
LyeSJ
GibbW
2002 Prostaglandins and mechanisms of preterm birth. Reproduction 124 1 17
22. FidelPLJr
RomeroR
WolfN
CutrightJ
RamirezM
1994 Systemic and local cytokine profiles in endotoxin-induced preterm parturition in mice. Am J Obstet Gynecol 170 1467 1475
23. RebmannT
2005 Severe acute respiratory syndrome: implications for perinatal and neonatal nurses. J Perinat Neonatal Nurs 19 332 345
24. LiZ
RenA
LiuJ
PeiL
ZhangL
2007 Maternal flu or fever, medication use, and neural tube defects: a population-based case-control study in Northern China. Birth Defects Res A Clin Mol Teratol 79 295 300
25. AcsN
BanhidyF
PuhoE
CzeizelAE
2005 Maternal influenza during pregnancy and risk of congenital abnormalities in offspring. Birth Defects Res A Clin Mol Teratol 73 989 996
26. HartertTV
NeuzilKM
ShintaniAK
MitchelEFJr
SnowdenMS
2003 Maternal morbidity and perinatal outcomes among pregnant women with respiratory hospitalizations during influenza season. Am J Obstet Gynecol 189 1705 1712
27. FranceEK
Smith-RayR
McClureD
HambidgeS
XuS
2006 Impact of maternal influenza vaccination during pregnancy on the incidence of acute respiratory illness visits among infants. Arch Pediatr Adolesc Med 160 1277 1283
28. HamiltonBE
MininoAM
MartinJA
KochanekKD
StrobinoDM
2007 Annual summary of vital statistics: 2005. Pediatrics 119 345 360
29. MartinJA
KungHC
MathewsTJ
HoyertDL
StrobinoDM
2008 Annual summary of vital statistics: 2006. Pediatrics 121 788 801
30. FioreAE
ShayDK
BroderK
IskanderJK
UyekiTM
2009 Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009. MMWR Recomm Rep 58 1 52
31. Centers for Disease Control and Prevention 2009 Receipt of influenza vaccine during pregnancy among women with live births—Georgia and Rhode Island, 2004–2007. MMWR Morb Mortal Wkly Rep 58 972 975
Štítky
Interné lekárstvoČlánok vyšiel v časopise
PLOS Medicine
2011 Číslo 5
- Statinová intolerance
- Očkování proti virové hemoragické horečce Ebola experimentální vakcínou rVSVDG-ZEBOV-GP
- Co dělat při intoleranci statinů?
- Pleiotropní účinky statinů na kardiovaskulární systém
- DESATORO PRE PRAX: Aktuálne odporúčanie ESPEN pre nutričný manažment u pacientov s COVID-19
Najčítanejšie v tomto čísle
- Low-Dose Adrenaline, Promethazine, and Hydrocortisone in the Prevention of Acute Adverse Reactions to Antivenom following Snakebite: A Randomised, Double-Blind, Placebo-Controlled Trial
- Effectiveness of Early Antiretroviral Therapy Initiation to Improve Survival among HIV-Infected Adults with Tuberculosis: A Retrospective Cohort Study
- Medical Students' Exposure to and Attitudes about the Pharmaceutical Industry: A Systematic Review
- Estimates of Outcomes Up to Ten Years after Stroke: Analysis from the Prospective South London Stroke Register